EXENS — Exosens SAS Cashflow Statement
0.000.00%
- €1.76tn
- €1.76tn
- €394.10m
Annual cashflow statement for Exosens SAS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -15.8 | -149 | 11.2 | 18.4 | 30.7 |
Depreciation | |||||
Non-Cash Items | 48.2 | 182 | 17.2 | 29.7 | 44.8 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 3.71 | -2.18 | -1.51 | -28.5 | -16.2 |
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 44.1 | 42.7 | 47.5 | 50.5 | 96.2 |
Capital Expenditures | -13.8 | -19.6 | -21.8 | -30.9 | -41.3 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | -1.67 | -33.7 | -68.7 | -31.4 |
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -13.8 | -21.3 | -55.5 | -99.6 | -72.7 |
Financing Cash Flow Items | -9.33 | -13.4 | -13.8 | -20.3 | -38.3 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.01 | -36.8 | 20.3 | 35.5 | 76.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 25.1 | -15.2 | 12.4 | -13.5 | 100 |